Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10301387 Methods for achieving therapeutically effective doses of anti-CD47 agents

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Stephen Willingham0

Anne Kathrin Volkmer0

Irving L. Weissman0

Jens-Peter Volkmer0

Jie Liu0

Maureen Howard0

Ravindra Majeti0

Susan Sweeney Prohaska0

Date of Patent

May 28, 2019

0

Patent Application Number

154233250

Date Filed

February 2, 2017

0

Patent Citations Received

US Patent 12084499 SIRP-α binding proteins and methods of use thereof

0

US Patent 11242404 Antibodies against signal-regulatory protein alpha and methods of use

0

US Patent 11591390 SIRP-α binding proteins and methods of use thereof

US Patent 11292850 Antibodies against signal-regulatory protein α and methods of use

US Patent 11401338 Antibodies against signal-regulatory protein alpha and methods of use

US Patent 11459388 Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

Patent Primary Examiner

0

Patent abstract

Methods are provided for treating a subject with a therapeutic dose of anti-CD47 agent by administering a primer agent prior to administering a therapeutically effective dose of an anti-CD47 agent to the subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10301387 Methods for achieving therapeutically effective doses of anti-CD47 agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool